secwatch.observer — SEC 8-K summary
======================================

Issuer:     Evofem Biosciences, Inc. (EVFM)
CIK:        0001618835
Form:       8-K
Filed at:   2025-03-26T23:59:59+00:00
Accession:  0001641172-25-000742
Event type: other_material
Sentiment:  positive
Materiality: 0.80
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Evofem signs manufacturing deal to cut PHEXXI cost ~55-60%; extends merger close to Sept 2025 with $1.5M investment
--------------------------------------------------------------------------------

- Windtree to manufacture PHEXXI; Evofem expects COGS reduction of 55-60%.
- No cost to Evofem for tech transfer; Windtree engaged a manufacturer.
- Fifth Amendment extends merger consummation date to Sept 30, 2025.
- Aditxt must invest $1.5M by April 7, 2025 via F-1 preferred or notes.
- Evofem to use best efforts to hold shareholder meeting by Sept 26, 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1618835/000164117225000742/0001641172-25-000742-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1618835/000164117225000742/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-000742

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer